Krebs Biochemicals & Industries Limited (BOM:524518)
India · Delayed Price · Currency is INR 54.00
+0.96 (1.81%)
At close: Jul 31, 2026
BOM:524518 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1.29 | 1.42 | 1.37 | 0.86 | 1.01 |
Cash & Short-Term Investments | 1.29 | 1.42 | 1.37 | 0.86 | 1.01 |
Cash Growth | -8.83% | 3.06% | 60.14% | -14.71% | -85.84% |
Accounts Receivable | 0.04 | 0.5 | 47.27 | 6.51 | 8.77 |
Other Receivables | - | 1.74 | 1.67 | 1.36 | 0.97 |
Receivables | 0.04 | 2.24 | 48.95 | 7.87 | 9.73 |
Inventory | 57.04 | 65.98 | 102.45 | 123.56 | 258.65 |
Prepaid Expenses | - | 4.73 | 3.76 | 5.18 | 4.93 |
Other Current Assets | 37.85 | 28.22 | 17.9 | 23.14 | 80.62 |
Total Current Assets | 96.22 | 102.59 | 174.42 | 160.61 | 354.93 |
Property, Plant & Equipment | 1,430 | 1,465 | 1,495 | 1,487 | 1,442 |
Other Intangible Assets | - | 18.47 | 18.47 | 18.47 | 18.47 |
Long-Term Deferred Charges | 2.88 | 4.72 | 6.56 | 8.4 | 10.24 |
Other Long-Term Assets | 103.29 | 99.84 | 87.73 | 75.22 | 72.26 |
Total Assets | 1,632 | 1,690 | 1,782 | 1,750 | 1,898 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 137.58 | 181.53 | 189.7 | 152.81 | 395.47 |
Accrued Expenses | 6.95 | 167.94 | 128.61 | 95.29 | 119.75 |
Short-Term Debt | 612.88 | 509.58 | 99.3 | 99.9 | 99.86 |
Current Portion of Long-Term Debt | - | - | 2.47 | 1.34 | 1.83 |
Other Current Liabilities | 373.24 | 176.21 | 198.27 | 141.71 | 163.73 |
Total Current Liabilities | 1,131 | 1,035 | 618.34 | 491.05 | 780.64 |
Long-Term Debt | 1,636 | 1,613 | 1,835 | 1,732 | 1,329 |
Pension & Post-Retirement Benefits | - | 27.68 | 25.56 | 22.9 | 23.32 |
Other Long-Term Liabilities | 493.86 | 477.3 | 495.01 | 498.03 | 515.73 |
Total Liabilities | 3,260 | 3,153 | 2,974 | 2,744 | 2,649 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 215.61 | 215.61 | 215.61 | 215.61 | 215.61 |
Additional Paid-In Capital | - | 1,180 | 1,180 | 1,180 | 1,180 |
Retained Earnings | - | -2,973 | -2,702 | -2,505 | -2,261 |
Comprehensive Income & Other | -1,843 | 114.45 | 114.45 | 114.45 | 114.45 |
Shareholders' Equity | -1,628 | -1,462 | -1,192 | -994.62 | -750.93 |
Total Liabilities & Equity | 1,632 | 1,690 | 1,782 | 1,750 | 1,898 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 2,248 | 2,122 | 1,937 | 1,834 | 1,431 |
Net Cash (Debt) | -2,247 | -2,121 | -1,935 | -1,833 | -1,430 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -104.17 | -98.36 | -89.77 | -85.01 | -66.32 |
Filing Date Shares Outstanding | 21.46 | 21.56 | 21.56 | 21.56 | 21.56 |
Total Common Shares Outstanding | 21.46 | 21.56 | 21.56 | 21.56 | 21.56 |
Working Capital | -1,034 | -932.67 | -443.92 | -330.44 | -425.71 |
Book Value Per Share | -75.83 | -67.83 | -55.29 | -46.13 | -34.83 |
Tangible Book Value | -1,628 | -1,481 | -1,211 | -1,013 | -769.4 |
Tangible Book Value Per Share | -75.83 | -68.68 | -56.15 | -46.99 | -35.69 |
Land | - | 484.19 | 484.19 | 484.19 | 484.19 |
Buildings | - | 275 | 273.02 | 266.37 | 256.92 |
Machinery | - | 2,350 | 2,335 | 2,248 | 2,106 |
Construction In Progress | - | 12.4 | 1.56 | 22.43 | 65.31 |